Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3 publications
NEO6860, modality-selective TRPV1 antagonist: a randomized, controlled, proof-of-concept trial in patients with osteoarthritis knee pain.
Journal: Pain reports
Published: June 11, 2018
Safety, Pharmacokinetics, and Pharmacodynamics Study in Healthy Subjects of Oral NEO6860, a Modality Selective Transient Receptor Potential Vanilloid Subtype 1 Antagonist.
Journal: The journal of pain
Published: June 09, 2016
Demographic and clinical features of inclusion body myositis in North America.
Journal: Muscle & nerve
Published: December 25, 2014
Showing 1-3 of 3
Last Updated: 09/26/2026